356 related articles for article (PubMed ID: 33826998)
1. Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants.
Yamaguchi Y; Akiyoshi T; Kawamura G; Imaoka A; Miyazaki M; Guengerich FP; Nakamura K; Yamamoto K; Ohtani H
Drug Metab Pharmacokinet; 2021 Jun; 38():100384. PubMed ID: 33826998
[TBL] [Abstract][Full Text] [Related]
2. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
Niwa T; Imagawa Y; Yamazaki H
Curr Drug Metab; 2014; 15(7):651-79. PubMed ID: 25429674
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition.
Dvorak Z
Toxicol Lett; 2011 Apr; 202(2):129-32. PubMed ID: 21333771
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.
Niwa T; Tani M; Suzuki A; Murakami M
Drug Metab Bioanal Lett; 2023; 16(2):73-80. PubMed ID: 37649294
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants.
Akiyoshi T; Saito T; Murase S; Miyazaki M; Murayama N; Yamazaki H; Guengerich FP; Nakamura K; Yamamoto K; Ohtani H
Drug Metab Dispos; 2011 Apr; 39(4):724-8. PubMed ID: 21212239
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7.
Godamudunage MP; Grech AM; Scott EE
Drug Metab Dispos; 2018 Sep; 46(9):1329-1337. PubMed ID: 29991575
[TBL] [Abstract][Full Text] [Related]
7. Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs.
Sakaeda T; Iwaki K; Kakumoto M; Nishikawa M; Niwa T; Jin JS; Nakamura T; Nishiguchi K; Okamura N; Okumura K
J Pharm Pharmacol; 2005 Jun; 57(6):759-64. PubMed ID: 15969931
[TBL] [Abstract][Full Text] [Related]
8. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
Moody DE; Liu F; Fang WB
J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
[TBL] [Abstract][Full Text] [Related]
9. Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression.
Svecova L; Vrzal R; Burysek L; Anzenbacherova E; Cerveny L; Grim J; Trejtnar F; Kunes J; Pour M; Staud F; Anzenbacher P; Dvorak Z; Pavek P
Drug Metab Dispos; 2008 Feb; 36(2):339-48. PubMed ID: 17998298
[TBL] [Abstract][Full Text] [Related]
10. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
[TBL] [Abstract][Full Text] [Related]
11. Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
Warrilow AG; Price CL; Parker JE; Rolley NJ; Smyrniotis CJ; Hughes DD; Thoss V; Nes WD; Kelly DE; Holman TR; Kelly SL
Sci Rep; 2016 Jun; 6():27690. PubMed ID: 27291783
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents.
Lamb DC; Kelly DE; Baldwin BC; Kelly SL
Chem Biol Interact; 2000 Mar; 125(3):165-75. PubMed ID: 10731517
[TBL] [Abstract][Full Text] [Related]
13. [Cytochrome P450 3A4 and Benzodiazepines].
Otani K
Seishin Shinkeigaku Zasshi; 2003; 105(5):631-42. PubMed ID: 12875231
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based inhibition profiles of erythromycin and clarithromycin with cytochrome P450 3A4 genetic variants.
Akiyoshi T; Ito M; Murase S; Miyazaki M; Guengerich FP; Nakamura K; Yamamoto K; Ohtani H
Drug Metab Pharmacokinet; 2013; 28(5):411-5. PubMed ID: 23514827
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.
Saad AH; DePestel DD; Carver PL
Pharmacotherapy; 2006 Dec; 26(12):1730-44. PubMed ID: 17125435
[TBL] [Abstract][Full Text] [Related]
16. Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.
Zhang S; Pillai VC; Mada SR; Strom S; Venkataramanan R
Xenobiotica; 2012 May; 42(5):409-16. PubMed ID: 22106961
[TBL] [Abstract][Full Text] [Related]
17. Origin of differences in susceptibility of Candida krusei to azole antifungal agents.
Marichal P; Gorrens J; Coene MC; Le Jeune L; Vanden Bossche H
Mycoses; 1995; 38(3-4):111-7. PubMed ID: 7477085
[TBL] [Abstract][Full Text] [Related]
18. Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine.
Biswas M; Shobana J; Jinda P; Sukasem C
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):165-174. PubMed ID: 37089014
[TBL] [Abstract][Full Text] [Related]
19. Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates.
Dilmaghanian S; Gerber JG; Filler SG; Sanchez A; Gal J
Chirality; 2004 Feb; 16(2):79-85. PubMed ID: 14712470
[TBL] [Abstract][Full Text] [Related]
20. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
